[1] S.L. Percival, P.G. Bowler, J. Dolman, Antimicrobial activity of silver containing dressings on wound microorganisms using an in vitro biofilm model, Int. Wound J 4 (2007) 186–191.
[2] A.R. Shahverdi, A. Fakhimi, H.R. Shahverdi, S. Minaian, Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli, Nanomedicine 3 (2007) 168–171.
[3] J.M. Nam, C.S. Thaxton, C.A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301 (2003) 1884–1886.
[4] J.P. Guggenbichler, M. Boswald, S. Lugauer, T. Krall, A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters, Infection 27 (1999) 16–23.
[5] I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275 (2004) 177–182.
[6] J.L. Elechiguerra, J.L. Burt, J.R. Morones, A. Camacho-Bragado, X. Gao, H.H. Lara, M.J. Yacaman, Interaction of silver nanoparticles with HIV-1, J nanobiotechnology 3 (2005) 6.
[7] H.H. Lara, N.V. Ayala-Nunez, L. Ixtepan-Turrent, C. Rodriguez-Padilla, Mode of antiviral action of silver nanoparticles against HIV-1, J Nanobiotechnol., 8 (2010) 1.
[8] B. Borrego, G. Lorenzo, J.D. Mota-Morales, H. Almanza-Reyes, F. Mateos, E. López-Gil, ... & N. Bogdanchikova, Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo. Nanomedicine: NBM, 12 (2016) 1185-1192.
[9] L. Sun, A.K. Singh, K. Vig, S.R. Pillai, S.R. Singh, Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol 4 (2008) 149–158.
[10] L. Lu, R.W. Sun, R. Chen, C.K. Hui, C.M. Ho, J.M. Luk, G.K. Lau, C.M. Che, Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13 (2008) 253–262.
[11] D.B. Pinto, S. Shukla, N. Perkas, A. Gedanken, R. Sarid, Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20 (2009) 1497–1502.
[12] J.V. Rogers, C.V. Parkinson, Y.W. Choi, J.L. Speshock, S.M. Hussain, A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation, Nanoscale Res Lett 3 (2008) 129–133.
[13] D. Morris, M. Ansar, J. Speshock, T. Ivanciuc, Y. Qu, A. Casola, R.P. Garofalo, Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection. Viruses 11 (2019) 732.
[14] D.X. Xiang, Q. Chen, L. Pang, C.L. Zheng, Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J virol methods 178 (2011) 137-142.
[15] D. Xiang, Y. Zheng, W. Duan, X. Li, J. Yin, S. Shigdar, B. Xiang, Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J nanomedicine 8 (2013) 4103.
[16] S. Gaikwad, A. Ingle, A. Gade, M. Rai, A. Falanga, N. Incoronato, M. Galdiero, Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J nanomed., 8 (2013) 4303.
[17] C. You, C. Han, X. Wang, Y. Zheng, Q. Li, X. Hu, H. Sun, The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep 39 (2012) 9193-9201.
[18] D.J. Barillo, D.E. Marx, Silver in medicine: a brief history BC 335 to present. Burns 4 (2014) 3-8.
[19] D. K. Tiwari, J. Takashi, J. Behari, Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats, Toxicol. Mech. Methods, 21 (2011) 13-24.
[20] N. Hadrup, H.R. Lam, Oral toxicity of silver ions, silver nanoparticles and colloidal silver–a review. Regul Toxicol Pharmacol, 68 (2014) 1-7.